Including: 1) By Drug Class: Proton Pump Inhibitors; H2 Antagonist; Acid Neutralizers; Pro-Motility Agents 2) By Formulation Type: Tablet; Liquid; Powder 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies Covering: Walmart Equate LLC; Private Label; Pfizer Inc; Johnson & Johnson Services Inc.; Procter & Gamble Co.
Antacids Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on antacids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Description:
Where is the largest and fastest growing market for antacids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antacids market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of covid 19 on supply chains and consumption patterns.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Proton Pump Inhibitors; H2 Antagonist; Acid Neutralizers; Pro-Motility Agents
2) By Formulation Type: Tablet; Liquid; Powder; Other Formulation Types
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
Companies Mentioned: Walmart Equate LLC; Private Label; Pfizer Inc; Johnson & Johnson Services Inc.; Procter & Gamble Co.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
1. Executive Summary
2. Antacids Market Characteristics
3. Antacids Market Trends And Strategies
4. Antacids Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Antacids Market Size and Growth
5.1. Global Antacids Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Antacids Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Antacids Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Antacids Market Segmentation
6.1. Global Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Proton Pump Inhibitors
H2 Antagonist
Acid Neutralizers
Pro-Motility Agents
6.2. Global Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Tablet
Liquid
Powder
Other Formulation Types
6.3. Global Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels
7. Antacids Market Regional And Country Analysis
7.1. Global Antacids Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Antacids Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Antacids Market
8.1. Asia-Pacific Antacids Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Antacids Market
9.1. China Antacids Market Overview
9.2. China Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Antacids Market
10.1. India Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Antacids Market
11.1. Japan Antacids Market Overview
11.2. Japan Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Antacids Market
12.1. Australia Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Antacids Market
13.1. Indonesia Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Antacids Market
14.1. South Korea Antacids Market Overview
14.2. South Korea Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Antacids Market
15.1. Western Europe Antacids Market Overview
15.2. Western Europe Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Antacids Market
16.1. UK Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Antacids Market
17.1. Germany Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Antacids Market
18.1. France Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Antacids Market
19.1. Italy Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Antacids Market
20.1. Spain Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Antacids Market
21.1. Eastern Europe Antacids Market Overview
21.2. Eastern Europe Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Antacids Market
22.1. Russia Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Antacids Market
23.1. North America Antacids Market Overview
23.2. North America Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Antacids Market
24.1. USA Antacids Market Overview
24.2. USA Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Antacids Market
25.1. Canada Antacids Market Overview
25.2. Canada Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Antacids Market
26.1. South America Antacids Market Overview
26.2. South America Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Antacids Market
27.1. Brazil Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Antacids Market
28.1. Middle East Antacids Market Overview
28.2. Middle East Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Antacids Market
29.1. Africa Antacids Market Overview
29.2. Africa Antacids Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Antacids Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Antacids Market Competitive Landscape And Company Profiles
30.1. Antacids Market Competitive Landscape
30.2. Antacids Market Company Profiles
30.2.1. Walmart Equate LLC
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Private Label
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Pfizer Inc
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Johnson & Johnson Services Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Procter & Gamble Co.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Antacids Market Other Major And Innovative Companies
31.1. Bayer AG
31.2. Novartis AG
31.3. Sanofi S.A.
31.4. Bristol Myers Squibb Company
31.5. AstraZeneca plc
31.6. Abbott Laboratories
31.7. GlaxoSmithKline plc
31.8. Takeda Pharmaceutical Company Limited
31.9. Boehringer Ingelheim GmbH
31.10. Reckitt Benckiser Group plc
31.11. WellSpring Pharmaceutical Corporation
31.12. Xiuzheng Pharmaceutical Group Company Limited
31.13. Bausch Health Companies Inc.
31.14. Sun Pharmaceuticals Industries Ltd.
31.15. Dr. Reddy's Laboratories Ltd
32. Global Antacids Market Competitive Benchmarking
33. Global Antacids Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Antacids Market
35. Antacids Market Future Outlook and Potential Analysis
35.1 Antacids Market In 2028 - Countries Offering Most New Opportunities
35.2 Antacids Market In 2028 - Segments Offering Most New Opportunities